Protagonist Therapeutics Ownership & Insider Activity

Protagonist Therapeutics Inc

PTGXNASDAQ

$132.04

-3.22-2.38%

Last update: Nov 9, 4:04 AM

Earnings: Q3 2026 Earnings were released on Thu Nov 5th, after the market close

Protagonist Therapeutics Ownership & Insider Activity - Benzinga

Protagonist Therapeutics (PTGX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.0% of shares outstanding. Institutional investors hold 74.7%.

Shares Outstanding

64.708M

Shares Float

55.683M

Insider Shares Owned

1.302M

Insider % Owned

2.0%

Institutional Shares Held

48.344M

Institutional % Held

74.7%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Sep 30, 2026	Asif Ali	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$82.75	$6.9M
Sep 8, 2026	Dinesh V. Patel, Ph.D.	PRESIDENT AND CEO	SELL-OPTIONS	—	$83.75	$15.5M
Aug 10, 2026	Dinesh V. Patel, Ph.D.	PRESIDENT AND CEO	SELL-OPTIONS	—	$85.24	$12.7M
Jun 23, 2026	William D Waddill	DIRECTOR	SELL-OPTIONS	—	$67.24	$913K
Jun 10, 2026	William D Waddill	DIRECTOR	SELL-OPTIONS	—	$61.32	$834K
May 29, 2026	William D Waddill	DIRECTOR	SELL-OPTIONS	—	$55.72	$791K
May 12, 2026	Dinesh V. Patel, Ph.D.	PRESIDENT AND CEO	SELL-OPTIONS	—	$60.85	$5.9M